Human Medical
Resume:
Elizabeth A. Johnson, Ph.D.
**** *. ******** ****, **. 364
Thousand Oaks, CA 91360
telephone 805-***-****
facsimile 805-***-****
******@*********.***
EDUCATION
College BS Chemistry, cum laude
Department of Chemistry
Wofford College, Spartanburg, SC
1978-1982
Graduate Ph.D. -- conferred July, 1987
Department of Microbiology and Immunology
Medical University of South Carolina, Charleston, SC
August 1982 - July 1987
Dissertation Production and characterization of a monoclonal antibody to an antigen present on
subsets of natural killer cells and human tumor cells.
POSITIONS HELD
Private Forensic Consultation May, 2003 - present
Senior Forensic Scientist Technical Associates, Inc.
4125 Market Street, Suite #3
Ventura, CA 93003
February 1997 May, 2003
Director DNA Laboratory
Joseph A. Jachimczyk Forensic Center
1885 Old Spanish Trail
Houston, TX 77054
September 1993 - December 1996
Supervisor DNA Laboratory / Serology Section
Joseph A. Jachimczyk Forensic Center
1885 Old Spanish Trail
Houston, TX 77054
April 1993 - September 1993
Assistant DNA Laboratory
Toxicologist Joseph A. Jachimczyk Forensic Center
1885 Old Spanish Trail
Houston, TX 77054
November 1991 - April 1993
Post-doctoral Fellow Department of Molecular Hematology
Advisor: Albert Deisseroth, M.D., Ph.D.
Chairman, Department of Hematology
M.D. Anderson Cancer Research Hospital
Houston, TX 77030
October 1988 - November 1991
Resume-EAJ-lh.doc Revised 11/1/2007 Page 1 of 6
Department of Microbiology and Immunology
Advisor: Alfred Tsang, Ph.D.
Medical University of South Carolina
Charleston, SC
September 1987 - September 1988
CONTINUING EDUCATION - FORENSICS
CLASSES and WORKSHOPS
Validation Workshop, International Symposium on Human Identification, October, 2007.
Y-STR Analysis on Forensic Casework, American Academy of Forensic Sciences, February 2004.
Expert Witness Workshop, Southwestern Working Group on DNA Analysis Methods (SWGDAM),
January, 2000.
Mitochondrial DNA Workshop, International Symposium on Human Identification, September, 1999.
FBI/SWGDAM STR Workshop, Austin, TX, 1998.
Statistics Workshop, International Symposium on Human Identification, September, 1996, 2002.
STR Workshop, The Promega Corporation, May, 1995.
Roche Amplitype Workshop, Roche Molecular Systems, December, 1992.
Armed Forces Institute of Pathology DNA Identification Laboratory, visiting scientist to learn methods of
mitochondrial DNA sequencing on aged remains, October, 1992.
Advanced Aspects of Forensic DNA Analysis (courtroom testimony), FBI Academy, June, 1992.
CONFERENCES
International Symposium on Human Identification 1992, 1993, 1994, 1995, 1996, 1997, 1999, 2001,
2002, 2003, 2004, 2007.
American Academy of Forensic Sciences 1992, 1993, 1994, 1995, 2001.
The Future of DNA Technology, Washington, DC, 1996.
CODIS Software Symposium, Quantico, VA, 1995.
Advances in DNA Technology, Bethesda, MD, 1992.
OTHER INFORMATION
CERTIFICATIONS
Certification of Qualification as Laboratory Director in Forensic Identity by the State of New York
Department of Heath, issued August 12, 2002.
Resume-EAJ-lh.doc Revised 11/1/2007 Page 2 of 6
APPOINTMENTS
California Senate Rules Committee Crime Laboratory Review Task Force, appointed October, 2007.
PROFESSIONAL SOCIETIES
Member of American Academy of Forensic Sciences
Association of Forensic DNA Analysts and Administrators (AFDAA)
(formerly Southwest Working Group on DNA Analysis Methods)
INVITED LECTURES
California Habeas Corpus Resource Center Spring Conference, June, 2007.
Washington State Bar Association, May, 2007.
CACJ/CPDA Capital Case Defense Seminar, February, 2007.
Texas Criminal Defense Lawyers Association, September, 2006.
Rusty Duncan Law Seminar, San Antonio, Texas, June, 2006.
Osgoode Professional Development Center Symposium on Forensic DNA Evidence, Toronto, Canada,
April, 2006.
Third Annual Forensic Science Conference DNA Cross-Examination College, Washington, D.C.,
September, 2005.
Texas Criminal Defense Lawyers Association, September, 2005.
Forensic Bioinformatics 4th Annual Conference, Dayton, OH, August 2005.
CACJ/CPDA Capital Case Defense Seminar, February, 2005.
Texas Criminal Defense Lawyers Association, August, 2004.
California Habeas Corpus Resource Center Spring Conference, May, 2004.
CACJ/CPDA Capital Case Defense Seminar, February, 2004.
Washington State Bar Association, September, 2003.
Texas Criminal Defense Lawyers Association, August, 2003.
Utah Criminal Defense Lawyers Association, April, 2003.
The Innocence Project, March, 2003.
Second Annual Texas Capital Defense Conference, October, 2002.
Guest lecturer, University of Texas Law School, Advanced Criminal Defense class, 1994, 1995, 1996,
1997, 1998, 1999, 2000, 2001, 2002, 2004, 2006.
California Public Defenders Association (CPDA), January, 2001.
Texas Criminal Defense Lawyers Association, October, 1997.
Arizona Public Defenders Seminar, April, 1997.
Resume-EAJ-lh.doc Revised 11/1/2007 Page 3 of 6
The Amersham Corporation, April, 1996.
College of the Mainland, April, 1995.
Southwest Association of Toxicologists, May, 1993.
BIBLIOGRAPHY
PUBLICATIONS
Taylor, M.S., A. Challed-Spong, and E.A. Johnson. Co-amplification of the HLA DQ and
1.
amelogenin genes: optimization and validation. J. Forensic Sciences, 42 (1), 1997.
2. Johnson, E., W. Henzel, and A. Deisseroth. An isoform of protein disulfide isomerase isolated
from chronic myelogenous leukemia cells alters complex formation between nuclear proteins and
regulatory regions of interferon-inducible genes. J. Biol. Chem., 267:144**-*****, 1992.
3. Seong, D., S. Sims, E. Johnson, J. Lyding, A. Lopez, M. Garovoy, M. Talpaz, H. Kantarjian, G.
Lopez-Berestein, C. Reading, and A. Deisseroth. Activation of class I HLA expression by TNF-
alpha and gamma-interferon is mediated through protein kinase C - dependent pathway in CML
cell lines. British Journal of Haematology, 78:359-367, 1991.
4. Deisseroth, A., O.M.Z. Howard, A. Wedrychowski, D. Seong, N. Paslidis, M. Romine, S. Sims,
C.V. Herst, T. Yuan, K. Wu, T. Lopez and E. Johnson. Summary and Future Directions, in
Chronic Myelogenous Leukemia: Molecular Approaches to Research and Therapy; A. Deisseroth
and R. Arlinghaus, eds., 1991, pp.469-475.
5. Wedrychowski, A., D. Seong, N. Paslidis, E. Johnson, O.M.Z. Howard, S. Sims, M. Talpaz, H.
Kantarjian, J. Hester, J. Turpin, G. Lopez-Berestein, J. Gutterman, E.J. Freireich and A.
Deisseroth. Characterization of nuclear proteins which bind to interferon-inducible transcriptional
enhancers in hematopoietic cells. J. Biol. Chem., 265:214**-*****, 1990.
6. Deisseroth, A., C.V. Herst, A. Wedrychowski, S. Sims, D. Seong, E. Johnson, T. Yuan, M.
Romine, N. Paslidis, P. Gao, L. Huston, D. Claxton, S. Kornblau, H, Kantarjian, M. Talpaz and C.
Reading. Future directions in molecular and genetic therapy of leukemias and solid tumors. M.D.
Anderson Cancer Bulletin, 1990.
7. Seong, D.C., S. Sims, E. Johnson, O.M.Z. Howard, J. Hester, M. Talpaz, H. Kantarjian and A.
Deisseroth. A phosphatase activity present in peripheral blood myeloid cells of CML patients but
not normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-
inducible genes. J. Clin. Invest., 86:1664-1670, 1990.
8. Warren, R.Q., E.A. Johnson, R.P. Donnelly, M.F. LaVia and K.Y. Tsang. Specificity of anti-
lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy
homosexuals. Clin. and Exp. Immunol., 73:68-73, 1988.
9. Tsang, K.Y., E.A. Johnson and M.F. LaVia. Anti-p24 antibody reactivity in Acquired
Immunodeficiency Syndrome (AIDS) related complex patients treated with Isoprinosine. Annals
of Internal Medicine, 107:595, 1988.
10. Johnson, E., L. Miribel, P. Arnaud and K.Y. Tsang. Purification of IgM monoclonal antibody
from murine ascitic fluid by a two step column chromatography procedure. Immunol. Lett.,
14:159-165, 1987.
Resume-EAJ-lh.doc Revised 11/1/2007 Page 4 of 6
ABSTRACTS
1. Ballard, K.D., R.S. Orkiszewski, P.R. DeForest, M.S. Taylor, E.A. Johnson, and L. Ragle: EDTA
testing in forensics: direct derivatization for GC-MS/MS analysis and the quantity of dried
bloodstain analyzed. Proceedings of the 45th ASMS Conference on Mass Spectrometry and Allied
Topics, Palm Springs, California, June 1-5, 1997, p. 54.
2. Ballard, K.D., R.S. Orkiszewski, M.S. Taylor, E.A. Johnson, and L. Ragle. DNA typing and the
determination of EDTA in forensic samples by GC-MS/MS. Presented at the Seventh
International Symposium on Human Identification, Scotsdale, AZ, 1996.
3. Ballard, K.D., R.S. Orkiszewski, M.S. Taylor, E.A. Johnson, and L. Ragle. Determination of
EDTA in forensic samples by capillary GC-MS and GC-MS/MS. Presented at the 44th ASMS
Conference on Mass Spectrometry and Allied Topics, Portland, Oregon, 1996.
4. Stacy, T., E.A. Johnson, J. Krebsbach, S. Bowne, and R. Cotton. Chemiluminescence of forensic
casework: a comparison of the hybridization and detection methods of three independent
laboratories. Presented at the Sixth International Symposium on Human Identification, Scotsdale,
AZ, 1995.
Taylor, M.S., A. Challed, and E.A. Johnson. Co-amplification of the amelogenin gene with DQ-
5.
utilizing the Amplitype reaction mix and amplification protocol. Presented at the Fifth
International Symposium on Human Identification, Scotsdale, AZ, 1994.
Taylor, M.S., A. Challed, and E.A. Johnson. Co-amplification of the amelogenin gene with DQ-
6.
utilizing the Amplitype reaction mix and amplification protocol. Presented at the California
Association of Criminalists spring meeting, Los Angeles, CA, 1994.
7. Johnson, E., and M. Pennington. Use of alkaline phosphatase-labeled probes and
chemiluminescence detection methods for establishing an RFLP data base and analysis of forensic
cases. Presented at the Fourth International Symposium on Human Identification, Scotsdale, AZ,
1993.
8. Johnson, E., W. Henzel, and A. Deisseroth. Elevated levels of phospholipase C alpha are
associated with alteration of complexes formed between interferon-inducible transcriptional
enhancers and nuclear proteins in cells of interferon resistant chronic myelogenous leukemia
(CML) patients. Presented at the annual meeting of the American Society for Hematology,
Denver, CO, 1991.
9. Johnson, E., D. Seong, A. Wedrychowski, S. Sims, M. Romine, L. Huston, R. Luttrell and A.
Deisseroth. A cytoplasmic phosphatase which is elevated in CML myeloid cells alters the binding
of nuclear proteins to interferon-inducible transcriptional enhancers. Presented at the annual
meeting of the American Society for Hematology, Boston, MA, 1990.
10. Tsang, K.Y., E.A. Johnson, L. Bishop, M.F. La Via H.H. Fudenberg and M.Arlen. Monoclonal
antibodies to human colon carcinoma-associated antigen(s). FASEB, Washington, DC (abstract
no.4322), 1987.
11. Trojanowska, M., K.Y. Tsang, E.A. Johnson, L. Bishop, M. Christian and R.Q. Warren.
Expression of c-myc, c-myb oncogenes and interleukin-2 receptor in human peripheral blood
mononuclear cells after treatment with an immunopotentiator (isoprinosine). FASEB,
Washington, DC (abstract no. 850), 1987.
12. Johnson, E.A., J. Minowada, M.F. La Via, and K.Y. Tsang. A monoclonal antibody to human NK
cells is reactive with various tumor cell lines. Federation of American Societies of Experimental
Biology (FASEB), Washington, DC (abstract no. 956), 1987.
13. Warren, R.Q., E.A. Johnson, R.P. Donnelly, M.F. LaVia, M.E. Christian and K.Y. Tsang.
Analysis of anti-peripheral blood mononuclear cell (PBMC) antibodies in sera from AIDS, ARC,
Resume-EAJ-lh.doc Revised 11/1/2007 Page 5 of 6
and healthy homosexuals. First Annual Conference of Clinical Immunology Society, Baltimore,
MD, 1986.
14. Johnson E.A., B. Koger, M. La Via and K.Y. Tsang. A shared antigen between human natural
killer (NK) cells and various tumor cells is recognized by an anti-NK monoclonal antibody. First
Annual Meeting, Clinical Applications of Flow Cytometry, Charleston, SC, 1986.
15. Johnson, E.A., K.Y. Tsang, B. Koger, B. Ward, R.Q. Warren, M. La Via and H.H. Fudenberg.
Production of a monoclonal antibody reactive with human natural killer cells. Federation
Proceedings, 44, No. 4, 1330, 1985.
Resume-EAJ-lh.doc Revised 11/1/2007 Page 6 of 6
Contact this candidate